In Vitro and In Vivo Studies Identify Important Features of Dengue Virus pr-E Protein Interactions

English version České info

Flaviviruses bud into the endoplasmic reticulum and are transported through the secretory pathway, where the mildly acidic environment triggers particle rearrangement and allows furin processing of the prM protein to pr and M. The peripheral pr peptide remains bound to virus at low pH and inhibits virus-membrane interaction. Upon exocytosis, the release of pr at neutral pH completes virus maturation to an infectious particle. Together this evidence suggests that pr may shield the flavivirus fusion protein E from the low pH environment of the exocytic pathway. Here we developed an in vitro system to reconstitute the interaction of dengue virus (DENV) pr with soluble truncated E proteins. At low pH recombinant pr bound to both monomeric and dimeric forms of E and blocked their membrane insertion. Exogenous pr interacted with mature infectious DENV and specifically inhibited virus fusion and infection. Alanine substitution of E H244, a highly conserved histidine residue in the pr-E interface, blocked pr-E interaction and reduced release of DENV virus-like particles. Folding, membrane insertion and trimerization of the H244A mutant E protein were preserved, and particle release could be partially rescued by neutralization of the low pH of the secretory pathway. Thus, pr acts to silence flavivirus fusion activity during virus secretion, and this function can be separated from the chaperone activity of prM. The sequence conservation of key residues involved in the flavivirus pr-E interaction suggests that this protein-protein interface may be a useful target for broad-spectrum inhibitors.

Vyšlo v časopise: In Vitro and In Vivo Studies Identify Important Features of Dengue Virus pr-E Protein Interactions. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001157
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001157

Souhrn

Zdroje

1. MorensDM

FolkersGK

FauciAS

2004 The challenge of emerging and re-emerging infectious diseases. Nature 430 242 249

2. MackenzieJS

GublerDJ

PetersenLR

2004 Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10 S98 109

3. WeaverSC

BarrettAD

2004 Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Micro 2 789 801

4. LindenbachBD

ThielH-J

RiceCM

2007 Flaviviruses: the viruses and their replication.

KnipeDM

HowleyPM

Fields' Virology. Fifth ed Philadelphia Lippincott, Williams and Wilkins 1101 1152

5. GublerDJ

2002 Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10 100 103

6. HalsteadSB

2007 Dengue. Lancet 370 1644 1652

7. KyleJL

HarrisE

2008 Global spread and persistence of dengue. Annu Rev Microbiol 62 71 92

8. WHO 2009 Dengue and Dengue Haemorrhagic Fever. WHO Fact Sheet N.117

9. WhiteheadSS

BlaneyJE

DurbinAP

MurphyBR

2007 Prospects for a dengue virus vaccine. Nat Rev Micro 5 518 528

10. MorensDM

FauciAS

2008 Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 299 214 216

11. MukhopadhyayS

KuhnRJ

RossmannMG

2005 A structural perspective of the flavivirus life cycle. Nat Rev Micro 3 13 22

12. van der SchaarHM

RustMJ

WaartsBL

van der Ende-MetselaarH

KuhnRJ

2007 Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81 12019 12028

13. van der SchaarHM

RustMJ

ChenC

van der Ende-MetselaarH

WilschutJ

2008 Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4 e1000244

14. ReyFA

HeinzFX

MandlC

KunzC

HarrisonSC

1995 The envelope glycoprotein from tick-borne encephalitis virus at 2A resolution. Nature 375 291 298

15. ModisY

OgataS

ClementsD

HarrisonSC

2003 A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100 6986 6991

16. ModisY

OgataS

ClementsD

HarrisonSC

2005 Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79 1223 1231

17. NybakkenGE

NelsonCA

ChenBR

DiamondMS

FremontDH

2006 Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80 11467 11474

18. KanaiR

KarK

AnthonyK

GouldLH

LedizetM

2006 Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80 11000 11008

19. ZhangY

ZhangW

OgataS

ClementsD

StraussJH

2004 Conformational changes of the flavivirus E glycoprotein. Structure (Camb) 12 1607 1618

20. KuhnRJ

ZhangW

RossmanMG

PletnevSV

CorverJ

2002 Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 717 725

21. ModisY

OgataS

ClementsD

HarrisonSC

2004 Structure of the dengue virus envelope protein after membrane fusion. Nature 427 313 319

22. BressanelliS

StiasnyK

AllisonSL

SturaEA

DuquerroyS

2004 Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23 728 738

23. LescarJ

RousselA

WienMW

NavazaJ

FullerSD

2001 The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105 137 148

24. RousselA

LescarJ

VaneyM-C

WenglerG

2006 Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure 14 75 86

25. GibbonsDL

VaneyM-C

RousselA

VigourouxA

ReillyB

2004 Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427 320 325

26. Sanchez-San MartinC

LiuCY

KielianM

2009 Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol 17 514 521

27. HarrisonSC

2008 Viral membrane fusion. Nat Struct Mol Biol 15 690 698

28. KielianM

ReyFA

2006 Virus membrane fusion proteins: more than one way to make a hairpin. Nat Rev Micro 4 67 76

29. Sanchez-San MartinC

SosaH

KielianM

2008 A stable prefusion intermediate of the alphavirus fusion protein reveals critical features of class II membrane fusion. Cell Host Microbe 4 600 608

30. LiaoM

Sanchez-San MartinC

ZhengA

KielianM

2010 In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol 84 5730 5740

31. ParoutisP

TouretN

GrinsteinS

2004 The pH of the secretory pathway: measurement, determinants, and regulation. Physiology (Bethesda) 19 207 215

32. WenglerG

1989 Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol 63 2521 2526

33. StadlerK

AllisonSL

SchalichJ

HeinzFX

1997 Proteolytic activation of tick-borne encephalitis virus by furin. J Virol 71 8475 8481

34. LiL

LokSM

YuIM

ZhangY

KuhnRJ

2008 The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319 1830 1834

35. YuIM

HoldawayHA

ChipmanPR

KuhnRJ

RossmannMG

2009 Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol 83 12101 12107

36. YuIM

ZhangW

HoldawayHA

LiL

KostyuchenkoVA

2008 Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319 1834 1837

37. LorenzIC

AllisonSL

HeinzFX

HeleniusA

2002 Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 76 5480 5491

38. LinYJ

WuSC

2005 Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus. J Virol 79 8535 8544

39. IvyJ

NakanoE

ClementsD

2000 Subunit immunogenic composition against dengue infection. US Patent 6,165,477

40. JunjhonJ

LausumpaoM

SupasaS

NoisakranS

SongjaengA

2008 Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J Virol 82 10776 10791

41. LiaoM

KielianM

2005 Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus-membrane fusion. J Cell Biol 171 111 120

42. DejnirattisaiW

JumnainsongA

OnsirisakulN

FittonP

VasanawathanaS

2010 Cross-reacting antibodies enhance dengue virus infection in humans. Science 328 745 748

43. KroschewskiH

SagripantiJL

DavidsonAD

2009 Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity. J Gen Virol 90 2457 2461

44. AllisonSL

StadlerK

MandlCW

KunzC

HeinzFX

1995 Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol 69 5816 5820

45. LorenzIC

KartenbeckJ

MezzacasaA

AllisonSL

HeinzFX

2003 Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol 77 4370 4382

46. HsiehSC

LiuIJ

KingCC

ChangGJ

WangWK

2008 A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles. Virology 374 338 350

47. CorverJ

OrtizA

AllisonSL

SchalichJ

HeinzFX

2000 Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology 269 37 46

48. WangPG

KudelkoM

LoJ

SiuLY

KwokKT

2009 Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS ONE 4 e8325

49. LisovaO

HardyF

PetitV

BedouelleH

2007 Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus. J Gen Virol 88 2387 2397

50. ThullierP

LafayeP

MegretF

DeubelV

JouanA

1999 A recombinant Fab neutralizes dengue virus in vitro. J Biotechnol 69 183 190

51. CrillWD

ChangGJ

2004 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 78 13975 13986

52. KonishiE

MasonPW

1993 Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol 67 1672 1675

53. DemaurexN

FuruyaW

D'SouzaS

BonifacinoJS

GrinsteinS

1998 Mechanism of acidification of the trans-Golgi network (TGN). In situ measurements of pH using retrieval of TGN38 and furin from the cell surface. J Biol Chem 273 2044 2051

54. ZhangX

FugereM

DayR

KielianM

2003 Furin processing and proteolytic activation of Semliki Forest virus. J Virol 77 2981 2989

55. StiasnyK

AllisonSL

SchalichJ

HeinzFX

2002 Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol 76 3784 3790

56. FritzR

StiasnyK

HeinzFX

2008 Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 183 353 361

57. NelsonS

PoddarS

LinTY

PiersonTC

2009 Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the “histidine switch” hypothesis. J Virol 83 12631 12635

58. SchmidtAG

YangPL

HarrisonSC

2010 Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6 e1000851

59. KaufmannB

ChipmanPR

HoldawayHA

JohnsonS

FremontDH

2009 Capturing a flavivirus pre-fusion intermediate. PLoS Pathog 5 e1000672

60. VashishthaM

PhalenT

MarquardtMT

RyuJS

NgAC

1998 A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit. J Cell Biol 140 91 99

61. TaylorGM

HansonPI

KielianM

2007 Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol 81 13631 13639

62. UmashankarM

Sanchez San MartinC

LiaoM

ReillyB

GuoA

2008 Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J Virol 82 9245 9253

63. ThomasJM

KlimstraWB

RymanKD

HeidnerHW

2003 Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J Virol 77 5598 5606

64. StiasnyK

KiermayrS

HolzmannH

HeinzFX

2006 Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. JVirol 80 9557 9568

65. WangP

ChenJ

ZhengA

NieY

ShiX

2004 Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Comm 315 439 444

66. ChatterjeePK

VashishthaM

KielianM

2000 Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion. J Virol 74 1623 1631

67. CassB

PhamPL

KamenA

DurocherY

2005 Purification of recombinant proteins from mammalian cell culture using a generic double-affinity chromatography scheme. Protein Expr Purif 40 77 85

68. PuriB

PoloS

HayesCG

FalgoutB

2000 Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain. Virus Genes 20 57 63

69. Chanel-VosC

KielianM

2004 A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J Virol 78 13543 13552

70. LiljeströmP

LusaS

HuylebroeckD

GaroffH

1991 In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol 65 4107 4113